Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Porteous

Showing results (91-100 of 299) with videos related to

Pageof 30
Sort By:
Journal of Psychopharmacology (Oxford, England)|February 28, 2019
Pharmaco-epidemiology of antidepressant exposure in a UK cohort record-linkage studyJonathan D Hafferty, Eleanor M Wigmore, David M Howard, et al.
Biological Psychiatry|February 20, 2013
Polygenic risk for schizophrenia is associated with cognitive change between childhood and old ageAndrew M McIntosh, Alan Gow, Michelle Luciano, et al.
Clinical Chemistry|July 9, 2021
Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General PopulationDorien M Kimenai, Anoop S V Shah, David A McAllister, et al.
Nature Neuroscience|October 31, 2006
A neuregulin 1 variant associated with abnormal cortical function and psychotic symptomsJeremy Hall, Heather C Whalley, Dominic E Job, et al.
Genomics|July 16, 2011
Differential global gene expression in cystic fibrosis nasal and bronchial epitheliumVarrie Ogilvie, Margaret Passmore, Laura Hyndman, et al.
Circulation|June 24, 2022
Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular DiseaseDorien M Kimenai, Leah Pirondini, John Gregson, et al.
Behavior Genetics|December 12, 2012
ADRB2, brain white matter integrity and cognitive ageing in the Lothian Birth Cohort 1936Donald M Lyall, Lorna M Lopez, Mark E Bastin, et al.
Human Molecular Genetics|February 2, 2002
The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectricsPaul Dickinson, Stephen N Smith, Sheila Webb, et al.
Thorax|March 26, 2013
A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosisEric W F W Alton, A Christopher Boyd, Seng H Cheng, et al.
Clinical Biochemistry|October 24, 2009
SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary diseasePatrícia Gomes-Alves, Margaret Imrie, Robert D Gray, et al.
Pageof 30

Showing results (91-100 of 299) with videos related to

Sort By:
Pageof 30
Journal of Psychopharmacology (Oxford, England)|February 28, 2019
Pharmaco-epidemiology of antidepressant exposure in a UK cohort record-linkage studyJonathan D Hafferty, Eleanor M Wigmore, David M Howard, et al.
Biological Psychiatry|February 20, 2013
Polygenic risk for schizophrenia is associated with cognitive change between childhood and old ageAndrew M McIntosh, Alan Gow, Michelle Luciano, et al.
Clinical Chemistry|July 9, 2021
Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General PopulationDorien M Kimenai, Anoop S V Shah, David A McAllister, et al.
Nature Neuroscience|October 31, 2006
A neuregulin 1 variant associated with abnormal cortical function and psychotic symptomsJeremy Hall, Heather C Whalley, Dominic E Job, et al.
Genomics|July 16, 2011
Differential global gene expression in cystic fibrosis nasal and bronchial epitheliumVarrie Ogilvie, Margaret Passmore, Laura Hyndman, et al.
Circulation|June 24, 2022
Socioeconomic Deprivation: An Important, Largely Unrecognized Risk Factor in Primary Prevention of Cardiovascular DiseaseDorien M Kimenai, Leah Pirondini, John Gregson, et al.
Behavior Genetics|December 12, 2012
ADRB2, brain white matter integrity and cognitive ageing in the Lothian Birth Cohort 1936Donald M Lyall, Lorna M Lopez, Mark E Bastin, et al.
Human Molecular Genetics|February 2, 2002
The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectricsPaul Dickinson, Stephen N Smith, Sheila Webb, et al.
Thorax|March 26, 2013
A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosisEric W F W Alton, A Christopher Boyd, Seng H Cheng, et al.
Clinical Biochemistry|October 24, 2009
SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary diseasePatrícia Gomes-Alves, Margaret Imrie, Robert D Gray, et al.
Pageof 30